Possible involvement of keratinocyte-derived microvesicle particles in human photosensitivity disorders
Authors:
- Risha AnnamrajuRARisha Annamraju
- Madison S. OwensMOMadison S. Owens
- Anita ThyagarajanATAnita Thyagarajan
- Danielle A. CorbinDCDanielle A. Corbin
- Catherine M.T. SherwinCSCatherine M.T. Sherwin
- Jade BryantJBJade Bryant
- Garrett W. FisherGFGarrett W. Fisher
- Winston R. OwensWOWinston R. Owens
- Alycia KetterAKAlycia Ketter
- Craig A. RohanCRCraig A. Rohan
- Michael G. KempMKMichael G. Kemp
- Robyn K. CrowRCRobyn K. Crow
Preprint
Abstract
Background: Previous murine studies have implicated acid sphingomyelinase-(aSMase) generated subcellular microvesicle particles (MVP) in photosensitivity. Objective: The current double-blinded placebo-controlled studies examined if a single localized ultraviolet B radiation (UVB) treatment generated more MVP in human subjects with self-identified photosensitivity versus normal controls. A topical 4% formulation of the aSMase inhibitor imipramine applied immediately after UVB blocked the MVP release and erythema responses. Erythema responses at 24 and 72 h in response to multiple UVB fluences and minimal erythema doses (MED) at 24 h and effects of imipramine were also tested. Results: Small cohorts of 10 adult self-identified photosensitive subjects and 10 controls were enrolled in these pilot studies which revealed increased levels of skin MVP in UVB-treated photosensitive subjects over controls which correlated with MED values. Moreover, post-UVB application of imipramine blunted UVB-induced MVP responses as well as tended to diminish erythema levels at 4 h but not at 24- or 72 h in photosensitive patients. Conclusion: Though limited by low numbers of self-identified subjects, these pilot studies provide some support for the hypothesis that MVP could be involved in multiple types of human photosensitivity responses and suggest aSMase inhibition as a potential therapeutic strategy.Keywords
This publication has 25 references indexed in Scilit:
- Evidence that keratinocyte microvesicle particles carrying platelet-activating factor mediate the widespread multiorgan damage associated with intoxicated thermal burn injuryJournal of Leukocyte Biology, 2024
- Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical TrialJournal of the American Academy of Dermatology, 2023
- “Shedding Light” on How Ultraviolet Radiation Triggers RosaceaJournal of Investigative Dermatology, 2020
- Photoimmunology: how ultraviolet radiation affects the immune systemNature Reviews Immunology, 2019
- Platelet-Activating Factor as an Effector for Environmental Stressors2019
- Characterization of clinical photosensitivity in cutaneous lupus erythematosusJournal of the American Academy of Dermatology, 2013
- Platelet-activating Factor Receptor Agonists Mediate Xeroderma Pigmentosum A PhotosensitivityJournal of Biological Chemistry, 2012
- Involvement of Platelet-Activating Factor in Ultraviolet B-Induced HyperalgesiaJournal of Investigative Dermatology, 2009
- Identification of New Functional Inhibitors of Acid Sphingomyelinase Using a Structure−Property−Activity Relation ModelJournal of Medicinal Chemistry, 2007
- Age dependence of ultraviolet light‐induced erythema following narrow‐band UVB exposurePhotodermatology, Photoimmunology & Photomedicine, 2002